Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toufic Renno

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Oncology|November 29, 2013
Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic interventionAlain Kfoury, François Virard, Toufic Renno, et al.
Gastroenterology|April 6, 2007
Precancerous lesions upon sporadic activation of beta-catenin in miceIsabelle Coste, Jean-Noël Freund, Simone Spaderna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
TLR3 can directly trigger apoptosis in human cancer cellsBruno Salaun, Isabelle Coste, Marie-Clotilde Rissoan, et al.
Oncotarget|July 2, 2016
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2Vincent Picco, Isabelle Coste, Marie-Josèphe Giraud-Panis, et al.
Cerebellum (London, England)|February 2, 2023
A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse ModelFabrice Faure, Lidia Yshii, Toufic Renno, et al.
Cancers|June 10, 2022
The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It ComplicatedRoumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, et al.
The Journal of Clinical Investigation|October 14, 2010
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformationIsabelle Coste, Katy Le Corf, Alain Kfoury, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Molecular landscapes of oral cancers of unknown etiologySophie Deneuve, Béatrice Fervers, Sergey Senkin, et al.
Journal of the National Cancer Institute|June 15, 2013
MyD88 in DNA repair and cancer cell resistance to genotoxic drugsAlain Kfoury, Katy Le Corf, Rana El Sabeh, et al.
Human Immunology|March 24, 2015
NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cellsCarine Al Akoum, Israa Akl, Redouane Rouas, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Oncology|November 29, 2013
Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic interventionAlain Kfoury, François Virard, Toufic Renno, et al.
Gastroenterology|April 6, 2007
Precancerous lesions upon sporadic activation of beta-catenin in miceIsabelle Coste, Jean-Noël Freund, Simone Spaderna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
TLR3 can directly trigger apoptosis in human cancer cellsBruno Salaun, Isabelle Coste, Marie-Clotilde Rissoan, et al.
Oncotarget|July 2, 2016
ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2Vincent Picco, Isabelle Coste, Marie-Josèphe Giraud-Panis, et al.
Cerebellum (London, England)|February 2, 2023
A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse ModelFabrice Faure, Lidia Yshii, Toufic Renno, et al.
Cancers|June 10, 2022
The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It ComplicatedRoumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, et al.
The Journal of Clinical Investigation|October 14, 2010
Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformationIsabelle Coste, Katy Le Corf, Alain Kfoury, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Molecular landscapes of oral cancers of unknown etiologySophie Deneuve, Béatrice Fervers, Sergey Senkin, et al.
Journal of the National Cancer Institute|June 15, 2013
MyD88 in DNA repair and cancer cell resistance to genotoxic drugsAlain Kfoury, Katy Le Corf, Rana El Sabeh, et al.
Human Immunology|March 24, 2015
NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cellsCarine Al Akoum, Israa Akl, Redouane Rouas, et al.
Pageof 3